Possible participation of the nitric oxide-cyclic GMP-protein kinase G-K+ channels pathway in the peripheral antinociception of melatonin

European Journal of Pharmacology

Volumn 596, Issue 1-3, 2008, Pages 70-76

  Hernández Pacheco, Alfonso ^a   Araiza Saldaña, Claudia Ivonne ^b   Granados Soto, Vinicio ^b   Mixcoatl Zecuatl, Teresa ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Formalin test; Guanylyl cyclase; K+ channels; Melatonin; Nitric oxide; Peripheral antinociception; Protein kinase G

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; APAMIN; CALCIUM CHANNEL; CHARYBDOTOXIN; CYCLIC GMP DEPENDENT PROTEIN KINASE; DRUG VEHICLE; FORMALDEHYDE; GLIBENCLAMIDE; KT 5823; MELATONIN; N(G) NITRO DEXTRO ARGININE METHYL ESTER; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; WISTAR RAT;

ANIMALS; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; FEMALE; MELATONIN; NITRIC OXIDE; PAIN; PAIN MEASUREMENT; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RATS; RATS, WISTAR;

EID: 53049092265     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.07.068     Document Type: Article

References (63)

1. 2 and opioid receptors. Pain 132 (2007) 273-280
2. Ambriz-Tututi M., Velázquez-Zamora D.A., Urquiza-Marín H., and Granados-Soto V. Analysis of the mechanism underlying the peripheral antinociceptive action of sildenafil in the formalin test. Eur. J. Pharmacol. 512 (2005) 121-127
3. + channel by cGMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7583-7587
4. Arreola-Espino R., Urquiza-Marín H., Ambriz-Tututi M., Araiza-Saldaña C.I., Caram-Salas N.L., Rocha-González H.I., Mixcoatl-Zecuatl T., and Granados-Soto V. Melatonin reduces formalin-induced nociception and tactile allodynia in diabetic rats. Eur. J. Pharmacol. 577 (2007) 203-210
5. Ayar A., Martin D.J., Ozcan M., and Kelestimur H. Melatonin inhibits high voltage activated calcium currents in cultured rat dorsal root ganglion neurones. Neurosci. Lett. 313 (2001) 73-77
6. Bilici D., Akpinar E., and Kiziltunc A. Protective effect of melatonin in carrageenan-induced acute local inflammation. Pharmacol. Res. 46 (2002) 133-139
7. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., and Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 368 (1994) 850-853
8. + channel pathway. Eur. J. Neurosci. 24 (2006) 1175-1181
9. Coderre T.J., Vaccarino A.L., and Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 535 (1990) 155-158
10. Cunha F.Q., Teixeira M.M., and Ferreira S.H. Pharmacological modulation of secondary mediator systems-cyclic AMP and cyclic GMP-on inflammatory hyperalgesia. Br. J. Pharmacol. 127 (1999) 671-678
11. Cuzzocrea S., Zingarelli B., Gilad E., Hake P., Salzman A.L., and Szabo C. Protective effect of melatonin in carrageenan-induced models of local inflammation: relationship to its inhibitory effect on nitric oxide production and its peroxynitrite scavenging activity. J. Pineal Res. 23 (1997) 106-116
12. Dickenson A.H., and Sullivan A.F. Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones. Neurosci. Lett. 83 (1987) 207-211
13. Duarte I.D., dos Santos I.R., Lorenzetti B.B., and Ferreira S.H. Analgesia by direct antagonism of nociceptor sensitization involves the arginine-nitric oxide-cGMP pathway. Eur. J. Pharmacol. 217 (1992) 225-227
14. Dubuisson D., and Dennis S.G. The formalin test: a quantitative study of the analgesic effect of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 4 (1977) 161-174
15. + channels. Annu. Rev. Pharmacol. Toxicol. 33 (1993) 597-637
16. El-Shenawy S.M., Abdel-Salam O.M., Baiuomy A.R., El-Batran S., and Arbid M.S. Studies on the anti-inflammatory and anti-nociceptive effects of melatonin in the rat. Pharmacol. Res. 46 (2002) 235-243
17. G-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle. Br. J. Pharmacol. 99 (1990) 602-606
18. Golombek D.A., Escolar E., Burin L.J., De Brito Sanchez M.G., and Cardinali D.P. Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism. Eur. J. Pharmacol. 194 (1991) 25-30
19. Golombek D.A., Pevet P., and Cardinali D.P. Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci. Biobehav. Rev. 20 (1996) 403-412
20. Granados-Soto V., Rufino M.O., Gomes Lopes L.D., and Ferreira S.H. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur. J. Pharmacol. 340 (1997) 177-180
21. Granados-Soto V., Arguelles C.F., and Ortiz M.I. The peripheral antinociceptive effect of resveratrol is associated with activation of potassium channels. Neuropharmacology 43 (2002) 917-923
22. + channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H1545-H1554
23. Heapy C.G., Jamieson A., and Russell N.J.W. Afferent C-fiber and A-delta activity in models of inflammation. Br. J. Pharmacol. 90 (1987) 164P
24. + current in rat cerebellar granule cells. Brain Res. 917 (2001) 182-190
25. Hunskaar S., and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30 (1987) 103-114
26. Jin J.G., Murthy K.S., Grider J.R., and Makhlouf G.M. Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Am. J. Physiol. 264 (1993) G470-G477
27. Lakin M.L., Miller C.H., Stott M.L., and Winters W.D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sci. 29 (1981) 2543-2551
28. Levy D., and Strassman A.M. Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade. J. Neurophysiol. 92 (2004) 766-772
29. Liu L., Yang T., Bruno M.J., Andersen O.S., and Simon S.A. Voltage gated ion channels in nociceptors; Modulation by cGMP. J. Neurophysiol. 92 (2004) 2323-2332
30. Lorenzetti B.B., and Ferreira S.H. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced intrathecal and peripheral analgesia. Inflamm. Res. 45 (1996) 308-311
31. Mantovani M., Kaster M.P., Pertile R., Calixto J.B., Rodrigues A.L., and Santos A.R. Mechanisms involved in the antinociception caused by melatonin in mice. J. Pineal Res. 41 (2006) 382-389
32. McNamara C.R., Mandel-Brehm J., Bautista D.M., Siemens J., Deranian K.L., Zhao M., Hayward N.J., Chong J.A., Julius D., Moran M.M., and Fanger C.M. TRPA1 mediates formalin-induced pain. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13525-13530
33. Mixcoatl-Zecuatl T., Aguirre-Bañuelos P., and Granados-Soto V. Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur. J. Pharmacol. 400 (2000) 81-87
34. Moro M.A., Russel R.J., Cellek S., Lizasoain I., Su Y., Darley-Usmar V.M., Radomski M.W., and Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1480-1485
35. 2 receptor-dependent. Neurosci. Lett. 360 (2004) 41-44
36. Onal S.A., Inalkac S., Kutlu S., and Kelestimur H. Intrathecal melatonin increases the mechanical nociceptive threshold in the rat. Agri. 16 (2004) 35-40
37. + channel pathway participates in the antinociceptive effect of diclofenac, but not of indomethacin. Pharmacol. Biochem. Behav. 76 (2003) 187-195
38. + channels pathway by gabapentin on the formalin test. Pharmacol. Biochem. Behav. 83 (2006) 420-427
39. Pang C.S., Tsang S.F., and Yang J.C. Effects of melatonin, morphine and diazepam on formalin-induced nociception in mice. Life Sci. 68 (2001) 943-951
40. Prado W.A., Schiavon V.F., and Cunha F.Q. Dual effect of local application of nitric oxide donors in a model of incision pain in rats. Eur. J. Pharmacol. 441 (2002) 57-65
41. Puig S., and Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 64 (1996) 345-355
42. Raghavendra V., Agrewala J.N., and Kulkarni S.K. Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. Eur. J. Pharmacol. 395 (2000) 15-21
43. Ray M., Mediratta P.K., Mahajan P., and Sharma K.K. Evaluation of the role of melatonin in formalin-induced pain response in mice. Indian J. Med. Sci. 58 (2004) 122-130
44. + channels. Br. J. Pharmacol. 129 (2000) 110-114
45. + channels. J. Physiol. 79 (1984) 259-264
46. + channel pathway. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3680-3685
47. Shavali S., Ho B., Govitrapong P., Sawlom S., Ajjimaporn A., Klongpanichapak S., and Ebadi M. Melatonin exerts its analgesic actions not by binding to opioid receptor subtypes but by increasing the release of beta-endorphin an endogenous opioid. Brain Res. Bull. 64 (2005) 471-479
48. 2-induced hyperalgesic paw. Br. J. Pharmacol. 134 (2001) 127-131
49. + channels: mechanism of peripheral antinociceptive action of the nitric oxide donor, sodium nitroprusside. Eur. J. Pharmacol. 400 (2000) 67-71
50. Stretton D., Miura M., Bevisi M.G., and Barnes P.J. Calcium-activated potassium channels mediate prejunctional inhibition of peripheral sensory nerves. Proc. Natl. Acad. Sci. U. S. A. 9 (1992) 1325-1329
51. Tegeder I., Schmidtko A., Niederberger E., Ruth P., and Geisslinger G. Dual effects of spinally delivered 8-bromo-cyclic guanosinemono-phosphate (8-bromo-cGMP) in formalin-induced nociception in rats. Neurosci. Lett. 332 (2002) 146-150
52. Tjølsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
53. Tomás-Zapico C., and Coto-Montes A. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J. Pineal Res. 39 (2005) 99-104
54. Tu Y., Sun R.Q., and Willis W.D. Effects of intrathecal injections of melatonin analogs on capsaicin-induced secondary mechanical allodynia and hyperalgesia in rats. Pain 109 (2004) 340-350
55. Ulugol A., Dokmeci D., Guray G., Sapolyo N., Ozyigit F., and Tamer M. Antihyperalgesic, but not antiallodynic, effect of melatonin in nerve-injured neuropathic mice: Possible involvements of the l-arginine-NO pathway and opioid system. Life Sci. 78 (2006) 1592-1597
56. Van den Top M., Buijs R.M., Ruijter J.M., Delagrange P., Spanswick D., and Hermes M.L. Melatonin generates an outward potassium current in rat suprachiasmatic nucleus neurones in vitro independent of their circadian rhythm. Neuroscience 107 (2001) 99-108
57. Vanecek J. Cellular mechanisms of melatonin action. Physiol. Rev. 78 (1998) 687-721
58. Wang X., and Robinson P.J. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68 (1997) 443-456
59. Wang T., Li S.R., Dai X., Peng Y.L., Chen Q., and Wang R. Effects of melatonin on orphanin FQ/nociceptin-induced hyperalgesia in mice. Brain Res. 1085 (2006) 43-48
60. Wheeler-Aceto H., and Cowan A. Standardization of the rat paw formalin test for the evaluation of analgesics. Psychopharmacol. 104 (1991) 35-44
61. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature 306 (1983) 686-688
62. Yu C.X., Zhu B., Xu S.F., Cao X.D., and Wu G.C. The analgesic effects of peripheral and central administration of melatonin in rats. Eur. J. Pharmacol. 403 (2000) 49-53
63. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 16 (1983) 109-110